Literature DB >> 22987332

Cancer statistics for Hispanics/Latinos, 2012.

Rebecca Siegel1, Deepa Naishadham, Ahmedin Jemal.   

Abstract

Hispanics/Latinos are the largest and fastest growing major demographic group in the United States, accounting for 16.3% (50.5 million/310 million) of the US population in 2010. In this article, the American Cancer Society updates a previous report on cancer statistics for Hispanics using incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. In 2012, an estimated 112,800 new cases of cancer will be diagnosed and 33,200 cancer deaths will occur among Hispanics. In 2009, the most recent year for which actual data are available, cancer surpassed heart disease as the leading cause of death among Hispanics. Among US Hispanics during the past 10 years of available data (2000-2009), cancer incidence rates declined by 1.7% per year among men and 0.3% per year among women, while cancer death rates declined by 2.3% per year in men and 1.4% per year in women. Hispanics have lower incidence and death rates than non-Hispanic whites for all cancers combined and for the 4 most common cancers (breast, prostate, lung and bronchus, and colorectum). However, Hispanics have higher incidence and mortality rates for cancers of the stomach, liver, uterine cervix, and gallbladder, reflecting greater exposure to cancer-causing infectious agents, lower rates of screening for cervical cancer, differences in lifestyle and dietary patterns, and possibly genetic factors. Strategies for reducing cancer risk among Hispanics include increasing utilization of screening and available vaccines, as well as implementing effective interventions to reduce obesity, alcohol consumption, and tobacco use.
Copyright © 2012 American Cancer Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22987332     DOI: 10.3322/caac.21153

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  252 in total

1.  The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.

Authors:  Sabine Krenn-Pilko; Uwe Langsenlehner; Tatjana Stojakovic; Martin Pichler; Armin Gerger; Karin S Kapp; Tanja Langsenlehner
Journal:  Tumour Biol       Date:  2015-07-29

2.  Feasibility of cold snare polypectomy in Japan: A pilot study.

Authors:  Yoji Takeuchi; Takeshi Yamashina; Noriko Matsuura; Takashi Ito; Mototsugu Fujii; Kengo Nagai; Fumi Matsui; Tomofumi Akasaka; Noboru Hanaoka; Koji Higashino; Hiroyasu Iishi; Ryu Ishihara; Henrik Thorlacius; Noriya Uedo
Journal:  World J Gastrointest Endosc       Date:  2015-11-25

3.  Psychological distress, social withdrawal, and coping following receipt of an abnormal mammogram among different ethnicities: a mediation model.

Authors:  Yamile Molina; Shirley A A Beresford; Noah Espinoza; Beti Thompson
Journal:  Oncol Nurs Forum       Date:  2014-09       Impact factor: 2.172

4.  Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis.

Authors:  ChongLek Lee; Hang He; Yongjian Jiang; Yang Di; Feng Yang; Ji Li; Chen Jin; Deliang Fu
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

5.  Management and risk factors for incomplete resection associated with jumbo forceps polypectomy for diminutive colorectal polyps: a single-institution retrospective study.

Authors:  Naoki Asayama; Shinji Nagata; Kenjiro Shigita; Yutaro Ogawa; Hirosato Tamari; Taiki Aoyama; Akira Fukumoto; Shinichi Mukai; Mayumi Kaneko
Journal:  Surg Endosc       Date:  2018-11-30       Impact factor: 4.584

6.  'Simple and easy:' providers' and latinos' perceptions of the fecal immunochemical test (FIT) for colorectal cancer screening.

Authors:  Claudia X Aguado Loi; Dinorah Martinez Tyson; Enmanuel A Chavarria; Liliana Gutierrez; Lynne Klasko; Stacy Davis; Diana Lopez; Tracy Johns; Cathy D Meade; Clement K Gwede
Journal:  Ethn Health       Date:  2018-01-10       Impact factor: 2.772

7.  Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.

Authors:  Yvonne N Flores; Rafael Velázquez-Cruz; Paula Ramírez; Manuel Bañuelos; Zuo-Feng Zhang; Hal F Yee; Shen-Chih Chang; Samuel Canizales-Quinteros; Manuel Quiterio; Guillermo Cabrera-Alvarez; Nelly Patiño; Jorge Salmerón
Journal:  Mol Biol Rep       Date:  2016-10-17       Impact factor: 2.316

8.  Improving cancer clinical research and trials with Hispanic populations: training and outreach efforts between Moffitt Cancer Center and the Ponce School of Medicine.

Authors:  Gwendolyn P Quinn
Journal:  Rev Recent Clin Trials       Date:  2014

9.  Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer.

Authors:  Jonathan L Silberstein; Stephen A Poon; Daniel D Sjoberg; Alexandra C Maschino; Andrew J Vickers; Aaron Bernie; Badrinath R Konety; W Kevin Kelly; James A Eastham
Journal:  BJU Int       Date:  2015-04-17       Impact factor: 5.588

10.  Tobacco use disparities by racial/ethnic groups: California compared to the United States.

Authors:  Kari-Lyn K Sakuma; Jamie Quibol Felicitas-Perkins; Lyzette Blanco; Pebbles Fagan; Eliseo J Pérez-Stable; Kim Pulvers; Devan Romero; Dennis R Trinidad
Journal:  Prev Med       Date:  2016-08-26       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.